Bayer stellt Zulassungsanträge in den USA und der EU für die Kombination der Krebstherapien Copanlisib und Rituximab
. - Einreichung in den USA für Patienten mit rezidivierenden indolenten B-Zell-Non-Hodgkin-Lymphomen (iNHL) - In der EU…
. - Einreichung in den USA für Patienten mit rezidivierenden indolenten B-Zell-Non-Hodgkin-Lymphomen (iNHL) - In der EU…
Zutectra® bietet in Zeiten der COVID-19-Pandemie eine praktische Heimtherapie-Option für Hochrisiko-Patienten nach Leber…
Global Diabetes Drugs Market – Overview The global diabetes drugs market is growing with a swift phase; mainly due to…
Market Scenario Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor and immune…
Global Diabetes Drugs Market - Scenario Diabetes is a metabolic disorder in which the body glucose level is elevated.…
Global Diabetes Drugs Market - Key Players The major player in the global diabetic drug market are Eli Lilly (US), No…
Global Contrast Media Market - Overview Contrast media are substances which are utilized to improve the contrast of fl…
Market Scenario: Mucormycosis (zygomycosis) is a serious but rare fungal infection caused by a group of molds called…
Global Diabetes Drugs Market - Key Players The major player in the global diabetic drug market are Eli Lilly (US), No…
Market Scenario Antihistamines are commonly used for the treatment of allergies across the globe. Food and pet allerg…